MTZ

MasTec

$212.65

-1.85%
Oct 9, 2026
Bobby Quantitative Model
MasTec, Inc. is a leading North American infrastructure construction company that provides engineering, building, installation, maintenance, and upgrade services across communications, clean energy and infrastructure, pipeline infrastructure, power delivery, and other end markets, operating through five reportable segments. As one of the largest specialty contractors in North America with roughly 37,000 employees, MasTec occupies a distinct position as a scaled, multi-segment platform that touches nearly every major infrastructure buildout theme — fiber and 5G communications, utility grid hardening, renewable energy, and pipeline work — rather than being a single-vertical niche player. The current investor narrative centers on whether MasTec can convert record backlog and AI/data-center-driven demand for electrical and communications infrastructure into durable earnings growth, with recent headlines highlighting an upgraded 2026 EPS outlook of roughly 42% growth and questions about whether the company can lead the next infrastructure investment cycle. At the same time, the debate has sharpened around execution risk, premium valuation, and competitive pressures, and the stock's severe recent drawdown suggests the market is increasingly skeptical that the growth story will translate into near-term shareholder returns.

People also watch

Quanta Services

Quanta Services

PWR

Analysis
Comfort Systems USA

Comfort Systems USA

FIX

Analysis
EMCOR

EMCOR

EME

Analysis
APi Group Corporation

APi Group Corporation

APG

Analysis
Jacobs Engineering Group

Jacobs Engineering Group

J

Analysis

BobbyInvestment Opinion: Should I buy MTZ Today?

The synthesized recommendation is a Hold, reflecting a balance between the compelling forward valuation and unanimous analyst bullishness against the severe technical breakdown and execution risks. The consensus 'strong_buy' rating and average target price of $392.80 imply 84.7% upside, but the stock's 42.97% three-month decline and negative free cash flow suggest the market is pricing in substantial skepticism. The core thesis is that MasTec offers deep value if it can achieve its forward EPS estimate of $23.55, but near-term momentum and cash flow concerns warrant caution.

Supporting evidence for a Hold includes the forward PE of 17.15x, which is below the broad market despite 23.4% revenue growth, and the PEG ratio of 0.293, indicating cheapness relative to growth. However, the trailing PE of 42.46x and PB ratio of 5.19x are elevated, and free cash flow remains weak with a PCF ratio of 31.0x. The company's ROE of 12.24% and ROA of 5.28% are moderate, and the debt-to-equity of 0.859 is manageable but not low. Analyst targets range from $305 to $518, with even the low target implying 43.4% upside, but the stock trades 30.3% below the lowest target, highlighting a disconnect.

Key risks that could invalidate the thesis include a failure to meet the 42% EPS growth outlook, continued negative free cash flow, and margin compression. The rating would upgrade to Buy if the stock stabilizes above $240-$250 and free cash flow turns positive, or downgrade to Sell if revenue growth decelerates below 15% or gross margins fall below 10%. Relative to its history, the stock is undervalued on a forward basis but fairly valued on trailing metrics, and the market is pricing in significant execution risk. This is an objective, data-driven assessment, not personalized financial advice.

Sign up to view all

MTZ 12-Month Price Forecast

The forward-looking view is neutral with medium confidence, balancing the compelling forward valuation and unanimous analyst bullishness against severe technical weakness and cash flow concerns. The stock's 42.97% three-month decline has created a deep value opportunity if MasTec achieves its $23.55 EPS estimate, but the negative free cash flow and margin volatility suggest execution risk is high. The base case (50% probability) assumes a partial recovery to $250-$350 as the company delivers moderate growth, while the bull case (25%) hinges on successful execution and multiple expansion. I would upgrade to bullish if free cash flow turns sustainably positive and gross margins hold above 12%, or downgrade to bearish if revenue growth decelerates below 10% or the stock breaks below $182.34.

Historical Price
Current Price $212.65
Average Target $300.00
High Target $518.00
Low Target $182.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on MasTec's 12-month outlook, with a consensus price target around $388.65 and implied upside of +82.8% versus the current price.

Average Target

$388.65

0 analysts

Implied Upside

+82.8%

vs. current price

Analyst Count

—

covering this stock

Price Range

$280 - $518

Analyst target range

MasTec is covered by 20 analysts with a consensus recommendation of "strong_buy" and a recommendation mean of 1.2381, indicating near-unanimous bullish sentiment on the sell side. The average price target of $392.80 implies approximately 84.7% upside from the current price of $212.65, a strikingly large gap that reflects either significant undervaluation or a sell-side community that has been slow to mark down estimates amid the stock's collapse. The consensus leans decisively bullish, and the institutional ratings data shows a wall of Buy/Overweight/Outperform ratings from Piper Sandler, Goldman Sachs, Mizuho, UBS, TD Cowen, KeyBanc, Truist, Baird, Citigroup, and Guggenheim — with no downgrades visible in the recent ratings history, though most of these ratings predate the worst of the drawdown.

The target range spans from a low of $305.00 to a high of $518.00, a spread of $213 or roughly 70% of the low target, which signals high uncertainty about the company's trajectory. The high target of $518 implies multiple expansion and successful execution on the AI/data-center infrastructure and clean energy backlog, while the low target of $305 still assumes 43.4% upside from current levels — meaning even the most cautious analyst sees substantial recovery. The estimated EPS range of $22.27 to $24.59 and revenue range of $29.1 billion to $31.4 billion for the forward period are relatively tight, suggesting the disagreement is more about multiple than fundamentals. The critical tension is that the stock trades 30.3% below the lowest analyst target, a disconnect that historically resolves either through a sharp price recovery or through analyst downgrades — and the recent price action, with the stock down 42.97% over three months, suggests the market is voting against the sell-side consensus.

Drowning in data?

Find the real signal!

Bulls vs Bears: MTZ Investment Factors

The bear case currently has stronger evidence due to the severe technical breakdown, negative free cash flow, and margin volatility, despite the bull case resting on a compelling forward valuation and unanimous analyst support. The stock's 42.97% three-month decline and 55.72% relative underperformance versus SPY over six months signal a broken momentum profile that has overwhelmed fundamental strengths. The single most important tension is whether the forward EPS estimate of $23.55 is achievable; if it is, the forward PE of 17.15x represents a deep value opportunity, but if execution falters, the stock could retest its 52-week low of $182.34. The market is currently voting against the sell-side consensus, creating a classic disconnect that will resolve either through a sharp recovery or analyst downgrades.

Bullish

  • Revenue growth accelerating at 23.4% YoY: Q2 2026 revenue of $4.374 billion grew 23.38% year-over-year from $3.545 billion in Q2 2025, and sequentially accelerated 14.2% from Q1 2026's $3.829 billion. This growth is diversified across Clean Energy and Infrastructure ($1.622 billion), Power Delivery ($1.246 billion), Communications ($889 million), and Pipeline Infrastructure ($643 million), reducing single-vertical risk.
  • Forward PE of 17.15x implies earnings inflection: The trailing PE of 42.46x collapses to a forward PE of 17.15x based on consensus EPS of $23.55, implying the market expects earnings to roughly 2.5x over the next year. This forward multiple is below the broad market despite superior growth, and the PEG ratio of 0.293 is strikingly low.
  • Analyst consensus strong buy with 84.7% upside: 20 analysts rate the stock a consensus 'strong_buy' with a mean recommendation of 1.2381, and the average price target of $392.80 implies 84.7% upside from the current $212.65. Even the lowest target of $305.00 still implies 43.4% upside, suggesting the sell-side sees substantial recovery potential.
  • Record backlog and AI-driven demand: Recent news highlights an upgraded 2026 EPS outlook of roughly 42% growth and record backlog, positioning MasTec to benefit from AI/data-center-driven demand for electrical and communications infrastructure. The company's multi-segment platform touches fiber, 5G, grid hardening, and renewable energy buildouts.

Bearish

  • Severe downtrend with -42.97% three-month decline: The stock has collapsed 42.97% over three months and 41.13% over six months, with a 1-month decline of 11.65% indicating accelerating selling pressure. Relative strength versus SPY is -46.10% over three months and -55.72% over six months, reflecting persistent alpha destruction.
  • Negative free cash flow and working capital drain: Q2 2026 free cash flow was negative $70.1 million due to a $187.8 million working capital drain and $91.5 million of capital expenditures, following Q1 2026's barely positive $2.1 million. TTM free cash flow is just $244.8 million, and the PCF ratio of 31.0x reflects weak cash conversion.
  • Thin and volatile margins with Q1 compression: Q2 2026 gross margin of 12.72% recovered from Q1 2026's 9.30% but remains below Q3 2025's 13.56%. The trailing gross margin of 9.55% and operating margin of 4.56% are characteristically low, and the quarterly variability raises questions about the durability of the Q2 recovery.
  • Premium valuation on PB and EV/EBITDA: Despite the price collapse, the PB ratio of 5.19x and EV/EBITDA of 17.33x remain elevated for a construction contractor. The PS ratio has compressed 84% from 7.43x in Q2 2026 to 1.18x now, but the market may still be pricing in optimistic forward estimates.

MTZ Technical Analysis

MasTec is in a pronounced downtrend that has overwhelmed its longer-term trend, with the shares down 42.97% over three months and 41.13% over six months despite a still-positive 1-year change of 1.22%. At a current price of $212.65 against a 52-week range of $182.34 to $441.43, the stock is trading at roughly 18.3% of its 52-week range — deeply in the lower quartile and only about 16.6% above its 52-week low. This positioning signals a broken momentum profile rather than a simple pullback: the stock has surrendered the vast majority of its prior advance and is now testing territory that, absent a fundamental catalyst, risks becoming a value trap rather than a value opportunity. The 1-year gain of just 1.22% versus the S&P 500's 16.0% over the same period underscores how much relative ground has been lost.

Short-term momentum is decisively negative and accelerating to the downside, with a 1-month decline of 11.65% stacking on top of the 3-month drop of 42.97%, indicating the selling pressure has not stabilized. The divergence between the modestly positive 1-year return (+1.22%) and the sharply negative 3-month and 6-month returns (-42.97% and -41.13%) is a classic late-stage trend reversal signal — the stock peaked and has been in distribution for two quarters. Relative strength metrics confirm the underperformance is severe and broad-based: -13.77% versus SPY over 1 month, -46.10% over 3 months, and -55.72% over 6 months, meaning MasTec has been a persistent source of alpha destruction. The most recent sessions show a modest bounce attempt from the $204 low on September 28 toward $228 on October 6, but the stock has already faded back to $212.65, suggesting rallies are being sold.

Key technical levels are well defined: the 52-week low at $182.34 is the critical support zone, roughly 14.3% below the current price, while the 52-week high at $441.43 represents formidable resistance more than double the current level. A breakdown below $182.34 would likely trigger further momentum-driven selling and open the door to new multi-year lows, whereas a sustained reclaim of the $240-$250 area (the September consolidation zone) would be the first evidence of a bottoming process. With a beta of 1.843, MasTec is approximately 84% more volatile than the broad market, meaning its 53.35% maximum drawdown is consistent with its high-beta profile and that position sizing must account for amplified moves in both directions. The short ratio of 3.87 days suggests short interest is meaningful but not extreme, leaving room for either a squeeze or further pressure depending on the next catalyst.

Beta

1.84

1.84x market volatility

Max Drawdown

-53.4%

Largest decline past year

52-Week Range

$182-$441

Price range past year

Annual Return

+1.2%

Cumulative gain past year

PeriodMTZ ReturnS&P 500
1m-11.6%+1.9%
3m-43.0%+3.9%
6m-41.1%+12.1%
1y+1.2%+19.2%
ytd-6.6%+14.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MTZ Fundamental Analysis

MasTec's revenue trajectory remains robust even as the stock has collapsed, with Q2 2026 revenue of $4.374 billion representing 23.38% year-over-year growth versus Q2 2025's $3.545 billion. The multi-quarter trend shows sequential acceleration through 2026: Q1 2026 revenue of $3.829 billion grew from Q1 2025's $2.848 billion, and Q2 2026's $4.374 billion topped Q1 2026 by 14.2%, while Q4 2025 revenue of $3.940 billion and Q3 2025's $3.967 billion establish a base above $3.9 billion. Segment data shows Clean Energy and Infrastructure at $1.622 billion and Power Delivery at $1.246 billion are the largest contributors, followed by Communications at $889 million and Pipeline Infrastructure at $643 million, indicating the growth is diversified across grid, renewable, and communications end markets rather than dependent on a single vertical. The 23.4% YoY growth rate is well above typical GDP-linked construction growth, implying MasTec is gaining share in secularly expanding infrastructure markets.

Profitability is positive but thin and somewhat volatile, with Q2 2026 net income of $130.1 million on a 2.98% net margin and gross margin of 12.72%, up from Q1 2026's 9.30% gross margin but below Q3 2025's 13.56%. The quarterly progression shows meaningful margin variability: Q1 2026 gross margin of 9.30% and operating margin of 3.70% were the weakest recent prints, while Q2 2026 recovered to 12.72% gross and 5.17% operating margin, and Q4 2025 delivered 10.08% gross and 5.28% operating margin. The trailing valuation data shows a gross margin of 9.55% and operating margin of 4.56%, with net margin of 2.79%, which is characteristically low for engineering and construction but consistent with the industry's pass-through, labor-intensive model. The key question is whether the Q2 margin recovery is durable or whether Q1's compression reflects structural cost pressure from labor and project mix.

Balance sheet and cash flow metrics reveal a company that is adequately capitalized but not generating abundant free cash flow, with debt-to-equity of 0.859, a current ratio of 1.323, and ROE of 12.24% against ROA of 5.28%. Free cash flow tells a more cautionary story: TTM free cash flow is just $244.8 million, and Q2 2026 free cash flow was negative $70.1 million due to a $187.8 million working capital drain and $91.5 million of capital expenditures, following Q1 2026's barely positive $2.1 million. The company has been actively repaying debt — $137.1 million in Q2 2026 and $142.8 million in Q1 2026 — while maintaining $315.6 million of cash, and the PCF ratio of 31.0x and EV/EBITDA of 17.3x suggest the market is paying a full price for cash generation that has yet to fully materialize. With interest coverage of roughly 4.8x and a cash flow-to-debt ratio of just 0.007 in the most recent quarter, MasTec's financial flexibility depends on continued EBITDA growth rather than current cash generation.

Quarterly Revenue

$4.4B

2026-06

Revenue YoY Growth

+23.4%

YoY Comparison

Gross Margin

12.7%

Latest Quarter

Free Cash Flow

$244804000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Communications
Clean Energy and Infrastructure
Power Delivery
Pipeline Infrastructure
Eliminations

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MTZ Overvalued?

Because MasTec is profitable — Q2 2026 net income of $130.1 million and trailing EPS of $0.024 — the PE ratio is the appropriate primary metric, and the trailing PE of 42.46x versus a forward PE of 17.15x is the single most important valuation signal in this dataset. The enormous gap between trailing and forward multiples implies the market expects earnings to roughly 2.5x over the next year, consistent with the analyst consensus EPS estimate of $23.55 and the company's upgraded 2026 EPS outlook of approximately 42% growth. This is a classic "earnings inflection" valuation setup: the stock looks expensive on trailing numbers but reasonable on forward numbers, and the entire investment case hinges on whether that forward estimate is achievable.

Relative to the broader Industrials and Engineering & Construction peer set, MasTec's valuation is mixed: the PS ratio of 1.18x and EV/Sales of 1.26x are modest for a company growing revenue at 23.4%, and the PEG ratio of 0.293 is strikingly low, suggesting the stock is cheap relative to its growth rate if the forward estimates hold. However, the PB ratio of 5.19x and EV/EBITDA of 17.33x are elevated for a construction contractor, and the PCF ratio of 31.0x reflects the weak free cash flow conversion. The forward PE of 17.15x is arguably the most compelling metric — it is below the broad market multiple despite superior growth — but this discount only exists because the market is discounting the reliability of those forward earnings.

Historically, MasTec's valuation has compressed dramatically: the PE ratio was 62.28x in Q2 2026, 103.12x in Q1 2026, and 29.70x in Q4 2025, while the PS ratio has fallen from 7.43x in Q2 2026 to the current 1.18x — a roughly 84% compression in the sales multiple. The PB ratio has similarly collapsed from 9.34x in Q2 2026 to 5.19x now, and the stock's historical PE band has ranged from the low-20s (Q3 2025 at 25.70x, Q4 2025 at 29.70x) to triple digits during earnings troughs. At a forward PE of 17.15x, the stock is now trading below its own recent historical range, which either signals a genuine value opportunity if earnings estimates are met or reflects the market's judgment that those estimates are too optimistic given execution risk and margin volatility.

PE

42.5x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 14x~147x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.3x

Enterprise Value Multiple

Investment Risk Disclosure

MasTec faces significant financial and operational risks, primarily stemming from its thin margins and weak cash flow generation. The company's trailing gross margin of 9.55% and operating margin of 4.56% leave little room for error, and Q1 2026's gross margin compression to 9.30% from Q3 2025's 13.56% highlights earnings volatility. Free cash flow is a major concern: Q2 2026 free cash flow was negative $70.1 million due to a $187.8 million working capital drain, and TTM free cash flow is only $244.8 million, resulting in a PCF ratio of 31.0x. With debt-to-equity of 0.859 and interest coverage of roughly 4.8x, the company's financial flexibility depends on continued EBITDA growth rather than current cash generation, and any revenue deceleration could strain liquidity.

Market and competitive risks are elevated given the stock's high beta of 1.843, which amplifies both upside and downside moves. The valuation remains premium on some metrics, with a PB ratio of 5.19x and EV/EBITDA of 17.33x, despite the PS ratio compressing 84% from 7.43x in Q2 2026 to 1.18x now. Competitive pressures are intensifying, as evidenced by recent news highlighting Dycom's $12.2 billion backlog and Sterling's 192% YoY growth, suggesting rivals are also capitalizing on infrastructure demand. Regulatory headwinds and macro sensitivity, including potential shifts in government infrastructure spending or interest rates, could further compress multiples, especially if the forward EPS estimate of $23.55 is not met.

The worst-case scenario involves a breakdown below the 52-week low of $182.34, which would likely trigger further momentum-driven selling and open the door to new multi-year lows. From the current price of $212.65, a decline to the 52-week low represents a 14.3% loss, but if the stock revisits its maximum drawdown of 53.35% from the 52-week high of $441.43, it could fall to around $206, implying a 3.1% loss from current levels—though a more severe scenario could see it drop to the analyst low target of $305, which is actually above the current price, indicating the sell-side expects recovery. However, if forward estimates are cut, the stock could fall below $182.34, potentially to $150 or lower, representing a 29.5% loss from current levels. The high beta means such a decline could happen rapidly, and investors should be prepared for significant volatility.

FAQ

The most severe risk is execution risk: MasTec must achieve its 42% EPS growth outlook, but Q1 2026 gross margin compression to 9.30% and negative free cash flow of -$70.1 million in Q2 2026 highlight the challenge. Financial risk is elevated due to thin margins (trailing gross margin of 9.55%) and a debt-to-equity of 0.859, with interest coverage of roughly 4.8x. Competitive risk is rising, as peers like Dycom and Sterling report strong backlogs and growth, potentially eroding MasTec's market share. Macro risk includes the high beta of 1.843, which amplifies downside in market selloffs, and sensitivity to infrastructure spending cycles. Ranked by severity: execution, financial, competitive, and macro risks.

The 12-month forecast includes three scenarios: a bull case (25% probability) targeting $392-$518 if MasTec achieves its EPS outlook and re-rates toward the analyst average; a base case (50% probability) targeting $250-$350 with moderate growth and margin stabilization; and a bear case (25% probability) targeting $182-$250 if execution falters and the stock retests its 52-week low. The base case is most likely, assuming revenue growth of 15-20% and gross margins around 11-12%. The key assumption is that free cash flow turns modestly positive and no major contract losses occur. The wide target range reflects high uncertainty, and the stock's high beta means outcomes can deviate significantly from these forecasts.

MTZ appears undervalued on forward metrics but fairly valued to overvalued on trailing metrics. The forward PE of 17.15x is below the broad market despite superior growth, and the PS ratio of 1.18x and EV/Sales of 1.26x are modest for a company growing at 23.4%. However, the trailing PE of 42.46x, PB ratio of 5.19x, and EV/EBITDA of 17.33x are elevated for a construction contractor. The market is pricing in significant execution risk, as evidenced by the stock trading 30.3% below the lowest analyst target of $305. If the company meets its $23.55 EPS estimate, the stock is undervalued; if estimates are cut, it could be overvalued. The valuation implies the market expects earnings to roughly 2.5x over the next year, a high bar that creates binary risk.

From a risk/reward perspective, MTZ presents a compelling but high-risk opportunity, with the average analyst target of $392.80 implying 84.7% upside from the current $212.65. The forward PE of 17.15x is attractive for a company growing revenue at 23.4% YoY, and the PEG ratio of 0.293 suggests undervaluation relative to growth. However, the stock has collapsed 42.97% over three months, and negative free cash flow of -$70.1 million in Q2 2026 raises execution concerns. The biggest downside risk is a retest of the 52-week low at $182.34, representing a 14.3% loss. For long-term investors with high risk tolerance, MTZ could be a good buy if it demonstrates margin stabilization and positive cash flow; for short-term traders, the downtrend suggests waiting for a bottoming signal.

MTZ is more suitable for long-term investment (minimum 2-3 years) given its growth stage, high volatility (beta of 1.843), and lack of dividend (payout ratio of 0). The company is in a capital-intensive expansion phase, with negative free cash flow and working capital needs, making near-term earnings visibility low. Short-term trading is risky due to the severe downtrend and 53.35% max drawdown, though the high beta offers trading opportunities for agile investors. A long-term horizon allows time for infrastructure spending cycles to play out and for MasTec to convert its record backlog into cash flow. Investors should monitor quarterly margin trends and free cash flow inflection as key milestones for holding.